Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» EyeGate Pharma Receives Orphan Drug Designation for Corneal Graft Rejection From U.S. FDA
EyeGate Pharma Receives Orphan Drug Designation for Corneal Graft Rejection From U.S. FDA
EyeGate Pharma Receives Orphan Drug Designation for Corneal Graft Rejection From U.S. FDA
Submitted by
admin
on January 10, 2009 - 12:37pm
Source:
MSNBC
News Tags:
EyeGate Pharma
EGP-437
dexamethasone phosphate
Headline:
EyeGate Pharma Receives Orphan Drug Designation for Corneal Graft Rejection From U.S. FDA
Do Not Allow Advertisers to Use My Personal information
